The GPR35 expression pattern is associated with overall survival in male patients with colorectal cancer

Pharmacol Rep. 2022 Aug;74(4):709-717. doi: 10.1007/s43440-022-00371-2. Epub 2022 May 27.

Abstract

Background: G protein-coupled receptor 35 (GPR35) is involved in the carcinogenesis; however, limited data exist on its relevance for overall survival (OS) and disease-specific survival (DSS) in patients with cancer.

Methods: We have examined The Cancer Genome Atlas dataset to check the relations between GPR35 expression pattern and OS or DSS of patients with colorectal cancer (CRC).

Results: The performed analysis showed a negative association between positive GPR35 expression Z score and OS in males, which remains statistically significant in advanced stages of colon (COAD) and rectal (READ) adenocarcinoma combined.

Conclusions: These findings suggest the prognostic value of early testing of GPR35 in male patients with an increased risk of CRC development and warrant further clinical confirmation.

Keywords: Biomarker; Colorectal cancer; Disease-specific survival; G protein-coupled receptor 35; GPR35; Overall survival.

MeSH terms

  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / metabolism
  • Colorectal Neoplasms* / pathology
  • Humans
  • Male
  • Prognosis
  • Receptors, G-Protein-Coupled* / genetics
  • Receptors, G-Protein-Coupled* / metabolism
  • Survival Rate

Substances

  • GPR35 protein, human
  • Receptors, G-Protein-Coupled